Scientists are developing blood tests that can detect cancer years before symptoms appear, including CRISPR-powered sensors and multi-cancer early detection tests that identify molecular warning signs in the bloodstream.
Tozaro, a Bedfordshire-based biotech company, has raised £6 million in funding led by Mercia Ventures to advance its Smart Polymer technology aimed at reducing the high production costs of cell and gene therapies.
Researchers have developed modified CAR T cells that overcome prostaglandin E2 suppression in solid tumors and a selective therapy targeting IGHV4-34 that spares healthy immune cells, addressing key limitations in current treatments.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07518329 |
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. |
NOT_YET_RECRUITING | PHASE1 |
| NCT07410676 |
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors |
RECRUITING | PHASE1/PHASE2 |
| NCT07305337 |
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education |
RECRUITING | NA |
| NCT07296445 |
A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) |
NOT_YET_RECRUITING | PHASE3 |
| NCT07167381 |
xDRIVE for Florida-based Cancer Patients |
RECRUITING | NA |
| NCT05473325 |
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) |
UNKNOWN | |
| NCT03594955 |
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome |
TERMINATED | PHASE1/PHASE2 |
| NCT03466944 |
PUMA (Paediatric Osseous Marrow Assessment) |
RECRUITING | |
| NCT02310997 |
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) |
TERMINATED | PHASE2 |
| NCT01941680 |
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant |
COMPLETED |
